Remus Pharmaceuticals Ltd 2025 Annual Report with Sustainability Disclosures
Company: Remus Pharmaceuticals Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 102
The report describes FY25 growth led by consolidated operational revenue of ₹620.36 crores and full-year integration of the U.S. subsidiary Espee. It highlights 170 trademarks filed, 35+ approvals, 620+ registered products and expansion into more than 40 countries. The report also details CSR work spanning healthcare, education, elderly welfare and environmental sustainability.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.